SEC Form 4 · accession 0001127602-18-034756
Elevance Health, Inc. · ELV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter D Haytaian
Officer — EVP & President, Commercial
Period of report
Nov 27, 2018
Accepted (ET)
Nov 29, 2018 · 4:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001156039
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Nov 27, 2018 | S | 700 | $277.29 | D | 47,006 | D | |
| Common StockF3 | Nov 27, 2018 | S | 2,500 | $278.22 | D | 44,506 | D | |
| Common StockF4 | Nov 27, 2018 | S | 900 | $279.30 | D | 43,606 | D | |
| Common StockF5 | Nov 27, 2018 | S | 400 | $280.35 | D | 43,206 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 26, 2018.
- F2This transaction was executed in multiple trades at prices ranging from $276.73 to $277.71. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $277.78 to $278.59. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $278.79 to $279.66. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5This transaction was executed in multiple trades at prices ranging from $280.29 to $280.43. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.